PRKCD and ischemia: Inhibition of PKCδ translocation has been shown to reduce ischemia and reperfusion-induced myocardial dysfunction and resulted in an improved regeneration of intracellular ATP25, while the specific PKCδ inhibitor KAI-9803 ameliorated injury associated with ischemia and reperfusion in animal models of acute myocardial infarction26.